Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

BW McCrindle, AH Rowley, JW Newburger, JC Burns… - circulation, 2017 - Am Heart Assoc
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis …

JW Newburger, M Takahashi, MA Gerber, MH Gewitz… - Circulation, 2004 - Am Heart Assoc
Background—Kawasaki disease is an acute self-limited vasculitis of childhood that is
characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral …

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)

B Assmus, V Schachinger, C Teupe, M Britten… - Circulation, 2002 - Am Heart Assoc
Background—Experimental studies suggest that transplantation of blood-derived or bone
marrow–derived progenitor cells beneficially affects postinfarction remodeling. The safety …

Intracoronary bone marrow–derived progenitor cells in acute myocardial infarction

V Schächinger, S Erbs, A Elsässer… - … England Journal of …, 2006 - Mass Medical Soc
Background Pilot trials suggest that the intracoronary administration of autologous
progenitor cells may improve left ventricular function after acute myocardial infarction …

Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association

TM Giglia, MP Massicotte, JS Tweddell, RJ Barst… - Circulation, 2013 - Am Heart Assoc
Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

[HTML][HTML] Transcoronary transplantation of progenitor cells after myocardial infarction

B Assmus, J Honold, V Schächinger… - … England Journal of …, 2006 - Mass Medical Soc
Background Pilot studies suggest that intracoronary transplantation of progenitor cells
derived from bone marrow (BMC) or circulating blood (CPC) may improve left ventricular …

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

V Schächinger, B Assmus, MB Britten, J Honold… - Journal of the American …, 2004 - jacc.org
Objectives: The Transplantation of Progenitor Cells And Regeneration Enhancement in
Acute Myocardial Infarction (TOPCARE-AMI) trial investigates both safety, feasibility, and …

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) mechanistic insights from serial contrast …

MB Britten, ND Abolmaali, B Assmus, R Lehmann… - Circulation, 2003 - Am Heart Assoc
Background—Experimental and initial clinical studies suggest that transplantation of
circulating blood–(CPC) or bone marrow–derived (BMC) progenitor cells may beneficially …

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST …

T Dill, V Schächinger, A Rolf, S Möllmann, H Thiele… - American Heart …, 2009 - Elsevier
BACKGROUND: Serial cardiac magnetic resonance imaging (CMR) is the reference
standard for evaluating left ventricular function, wall motion, and infarct size in patients with …

The emerging role of the endocannabinoid system in cardiovascular disease

P Pacher, S Steffens - Seminars in immunopathology, 2009 - Springer
Endocannabinoids are endogenous bioactive lipid mediators present both in the brain and
various peripheral tissues, which exert their biological effects via interaction with specific G …